Below are the most recent publications written about "Ovarian Neoplasms" by people in Profiles.
-
Bataycan A, Nurudeen O, Mohl JE, Mitchell KB, Leung MY. An Integrative Variant Scoring Function for Finding Novel Genes Associated with Ovarian and Thyroid Cancer. Int J Environ Res Public Health. 2026 Mar 26; 23(4).
-
Hurwitz LM, O'Brien KM, Townsend MK, Reid BM, Fridley BL, Fan W, Schabath MB, Bodelon C, Chan AT, Fortner RT, H?kansson N, Harris HR, Lacey JV, Liao LM, Merritt MA, Patel AV, Poynter JN, Robien K, Sandler DP, Wentzensen N, Wolk A, Zheng W, Tworoger SS, Trabert B. Longer-term aspirin use and subsequent ovarian cancer risk in the Ovarian Cancer Cohort Consortium. Int J Epidemiol. 2026 Feb 18; 55(2).
-
Chambers LM, Chalif J, Yao M, Reizes O, Rose PG, Michener CM, Vargas R. Gram-positive targeting antibiotics are associated with progression and death in women with platinum-sensitive recurrent high grade epithelial ovarian cancer. J Gynecol Oncol. 2026 01; 37(1):e69.
-
Chen Q, Dorji JP, Perera SG, Li P, Aijaz F, Ihuoma LC, Matsui H, Awah CU. In vivo inhibition of c-MYC in the metastatic drug-resistant ovarian cancer cells down regulates the c-MYC-PD-L1-PAX8-p21 to achieve therapeutic efficacy. BMC Cancer. 2025 Dec 10; 26(1):68.
-
Dickinson CF, Flipse SM, Wood JS, Bistran E, Bland AM, Sprague DJ, DeJohn AM, Choo YM, Hanna GS, Yoshida WY, Williamson RT, Tius MA, Hamann MT. Aleutianamine B, A Novel Chiral Sulfoxide Isolated from Latrunculia spp. and Generated via Semi-Synthesis, Exhibits Selectivity for Ovarian Cancer Cells. J Nat Prod. 2026 Jan 23; 89(1):73-81.
-
Ghisoni E, Benedetti F, Minasyan A, Desbuisson M, Cunnea P, Grimm AJ, Fahr N, Capt C, Rayroux N, De Carlo F, Gulhan DC, Dagher J, Barras D, Morotti M, Mar?n-Jim?nez JA, Chap BS, Santoro T, Spagnol G, Fleury M, Fortis K, Dorier J, Townsend MK, Tissot S, Rusakiewicz S, Ferreira HJ, Kraemer AI, Bassani-Stenberg M, Swisher EM, Kandalaft LA, Mastroyannis SA, Montone KT, Powell DJ, Banerjee S, Terry KL, Tworoger SS, Pittet MJ, Tanyi JL, Coukos G, Merritt MA, Fotopoulou C, Conejo-Garcia JR, Laniti DD. Myeloid cell networks govern re-establishment of original immune landscapes in recurrent ovarian cancer. Cancer Cell. 2025 Aug 11; 43(8):1568-1586.e10.
-
McLoughlin K, Merritt MA. Opportunistic salpingectomy for prevention of ovarian cancer among the general population. Curr Opin Obstet Gynecol. 2025 Oct 01; 37(5):340-345.
-
Wamba BEN, Mondal T, Freenor V F, Shaheed M, Pang O, Bedinger D, Legembre P, Devel L, Bhatnagar S, Leiserowitz GS, Tushir-Singh J. Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. Nat Commun. 2025 Jul 01; 16(1):5748.
-
Fu Z, Borho L, Taylor SE, Kelemen LE, DeFazio A, Webb PM, K?bel M, Meagher NS, Na R, Antoniou AC, Brand AH, Kennedy CJ, Nevins N, Pharoah PDP, Shvetsov YB, Winham SJ, Alsop J, Beckmann MW, Bolithon A, Boros J, Bowtell DDL, Brenton JD, Carney ME, Chudecka-Glaz A, Cook LS, Cybulski C, Fasching PA, Fereday S, Fortner RT, Garc?a MJ, Goode EL, Goodman MT, Gronwald J, Hartmann A, Hernandez BY, H?gdall E, Huntsman DG, Jensen A, Jimenez-Linan M, Joseph JM, Karlan BY, Kaznowska E, Kjaer SK, Kluz T, Koziak JM, Lester J, Longacre TA, Lycke M, McGuire V, Moysich KB, Murphy RA, Orsulic S, Ramus SJ, Rodr?guez-Antona C, Rothstein JH, Samra S, Sieh W, Steed H, Sundfeldt K, Talhouk A, Ucinski J, Wang C, Wentzensen N, Whittemore AS, Wilkens LR, Songer T, Brooks MM, Tang L, Modugno F. Ovarian cancer risk and survival according to tumor sex hormone receptor expression: An ovarian Cancer association consortium and ovarian tumor tissue analysis consortium pooled analysis. Gynecol Oncol. 2025 07; 198:112-129.
-
Rivera-Serrano M, Flores-Col?n M, Valiyeva F, Mel?ndez LM, Vivas-Mej?a PE. Upregulation of MMP3 Promotes Cisplatin Resistance in Ovarian Cancer. Int J Mol Sci. 2025 Apr 24; 26(9).